ENVERIC BIOSCIENCES, INC. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENVERIC BIOSCIENCES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-12-31 was $0.00.
- ENVERIC BIOSCIENCES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-09-30 was $507.68K.
- ENVERIC BIOSCIENCES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-06-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2016-03-31 was $83.19K.
- ENVERIC BIOSCIENCES, INC. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2016 was $590.87K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | $590.87K 10-K/A · filed 2017-04-04 |
| 2016-09-30 | $507.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | |
| 2016-03-31 | $83.19K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |